Medicina
Focused Ultrasound Trial Targets Schizophrenia Hallucinations at UCSF
Psychiatrists at the University of California San Francisco have started a first-in-human trial using low-intensity focused ultrasound to suppress auditory hallucinations in patients with schizophrenia. The study tests whether acoustic pulses delivered through the skull can alter deep brain activity without surgery. More than 70 percent of people with schizophrenia hear voices, and about 40 percent do not find relief through antipsychotic drugs.
